Sara Toyloy
Directeur/Membre du Conseil chez Tissium SA
Profil
Sara Toyloy is an Independent Director at Tissium SA since 2022.
Prior to this, she served as an Independent Director at Shockwave Medical, Inc. from 2021 to 2024.
She completed her undergraduate degree at California State University-East Bay.
Postes actifs de Sara Toyloy
| Sociétés | Poste | Début |
|---|---|---|
Tissium SA
 Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Directeur/Membre du Conseil | 26/09/2022 |
Anciens postes connus de Sara Toyloy
| Sociétés | Poste | Fin |
|---|---|---|
| SHOCKWAVE MEDICAL | Directeur/Membre du Conseil | 31/05/2024 |
Formation de Sara Toyloy
| California State University-East Bay | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Shockwave Medical, Inc.
 Shockwave Medical, Inc. Medical SpecialtiesHealth Technology Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA. | Health Technology |
Tissium SA
Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Health Technology |
